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ABSTRACT 
 
 
BACKGROUND: Type 2 diabetes and cardiovascular disease (CVD) are among the leading 
causes of death in the United States.  The Metabolic Syndrome, which comprises a cluster of 
cardiometabolic risk factors, puts individuals at increased risk for these diseases.  It is therefore 
important that people with Metabolic Syndrome, at high risk for CVD and type 2 diabetes, are 
identified and treated.  Since it may not often be practical to obtain the laboratory measures 
necessary for diagnosing the Metabolic Syndrome, simple anthropometric measures are a useful 
way of quickly identifying individuals at increased risk for the Metabolic Syndrome. 
OBJECTIVE:  The purpose of this thesis is to evaluate the utility of three of the most 
commonly used anthropometric measures – Body Mass Index (BMI), Waist Circumference 
(WC), and Waist-to-Height Ratio (WC) – for classifying individuals with and without the 
Metabolic Syndrome and its component risk factors in the United States.  Using Receiver 
Operating Characteristic (ROC) curve analysis and Area Under the Curve (AUC) statistics, this 
thesis will assess the utility of each body measurement and compare it to BMI. 
METHODS:  A large, multi-ethnic, nationally representative sample from the National Health 
and Nutrition Examination Survey (NHANES) 2007-2010 was used for this analysis.  The study 
sample was restricted to adults aged 20-65 with complete information on height, weight, waist 
circumference, blood pressure, HDL cholesterol, fasting glucose, and triglycerides (n=3,769).  In 
order to compare the utility of different anthropometric measures for classification, weighted 
ROC curves were constructed for each anthropometric measure-outcome combination and AUC 
statistics were compared.  AUC statistics were calculated by approximating the definite integral 
of the ROC curves with the trapezoidal rule.  Variances for AUC statistics and differences in 
AUC statistics were estimated with jackknife repeated replication.  Analyses were completed for 
the entire sample and separately for non-Hispanic whites, non-Hispanic blacks, and Mexican 
Americans. 
RESULTS:  For the entire sample, WC (AUC=0.752) did a better job than BMI (AUC=0.728) 
at classifying individuals with and without the Metabolic Syndrome (p<0.001) and all of the 
component risk factors except for HDL cholesterol.  WHtR (AUC=0.740) performed better than 
BMI at classifying the Metabolic Syndrome (p=0.048), high blood pressure, and high 
triglycerides.  The performance of WHtR was inconsistent across race.  For every analysis in the 
overall sample and in the race subgroups, WC performed significantly better than BMI or no 
different from BMI, except for low HDL cholesterol among Mexican Americans where it 
performed significantly worse than BMI. 
CONCLUSION:  Waist circumference should be considered, especially over BMI, for risk 
stratification in clinical settings and research.  Further research should attempt to identify 
optimum waist circumference cut points for use in the US population.   
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Chapter I 
INTRODUCTION 
 
1.1  Background 
 Type 2 diabetes and cardiovascular disease (CVD) are among the leading causes of death 
in the United States (Murphy, Xu, & Kochanek, 2013; CDC, 2014).  The Metabolic Syndrome, 
which comprises a cluster of cardiometabolic risk factors, puts individuals at increased risk for 
these diseases (Ford, Li, & Sattar, 2008; Gami et al., 2007).  It is therefore important that people 
with Metabolic Syndrome, at high risk for CVD and type 2 diabetes, are identified and treated.  
Since it may not often be practical to obtain the laboratory measures necessary for diagnosing the 
Metabolic Syndrome, simple anthropometric measures are a useful way of quickly identifying 
individuals at increased risk for the Metabolic Syndrome and thus type 2 diabetes and CVD.   
 
1.2  Study Purpose 
 The purpose of this thesis is to evaluate the utility of three of the most commonly used 
anthropometric measures – Body Mass Index (BMI), Waist Circumference (WC), and Waist-to-
Height Ratio (WHtR) – for classifying individuals with and without the Metabolic Syndrome and 
its component risk factors.  Using Receiver Operating Characteristic (ROC) curve analysis and 
Area Under the Curve (AUC) statistics, this thesis will assess the absolute utility of each body 
measurement and compare it to BMI which may be considered the gold standard for 
anthropometric measures.   
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Chapter II 
REVIEW OF LITERATURE 
 
2.1  Cardiovascular Disease, Type II Diabetes Mellitus, and the Metabolic Syndrome 
 CVD is the leading cause of death for both men and women in the United States, killing 
about 600,000 people every year (Murphy et al., 2013).  The cost of health care services, 
medications, and lost productivity related to CVD in the US each year totals $108 billion 
(Heidenreich et al., 2011).  In the US, morbidity and mortality related to CVD is highest among 
non-Hispanic blacks (CDC, 2005; Bauer, Briss, Goodman, & Bowman, 2014) and projections 
have indicated that this disparity will continue into the future (Heidenreich et al., 2011). 
 Type 2 diabetes was the seventh leading cause of death in the United States in 2010 and 
was listed as the underlying cause of death on 69,071 death certificates and mentioned as a cause 
of death on a total of 234,051 death certificates.  Another 29.1 million people, or 9.3% of the 
United States population, are thought to be currently living with diabetes, 8.1 million of which 
are unaware of their diabetic status (CDC, 2014).  Diabetes cost the United States $245 billion in 
direct and indirect medical costs in 2012 (CDC, 2014).  Type 2 diabetes was previously referred 
to as adult-onset diabetes and is distinguished from type 1 diabetes, which was previously 
referred to as juvenile-onset diabetes.  It’s estimated that type 2 diabetes accounts for 90% to 
95% of all diagnosed cases of diabetes (CDC, 2014).  For the purposes of this thesis the term 
‘diabetes’ will refer only to type 2 diabetes. 
 The prevalence of diabetes remained fairly constant in the US from 1980 through 1990 
but has steadily increased since 1990 (CDC, 2012).  The US also saw a dramatic nationwide 
increase in obesity between 1990 and 2010 (CDC, 2014).  In 2010, it was projected that by 2050 
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as many as 1 in 3 adults in the United States could have diabetes if the current trend continues 
unabated (Boyle, Thompson, Gregg, Barker, & Williamson, 2010).  There are also significant 
racial disparities in diabetes morbidity.  From 2010 to 2012 in the United States it was estimated 
that among people aged 20 years or older, 13.2 % of non-Hispanic blacks and 12.8% of 
Hispanics had diagnosed diabetes compare to 7.6% of non-Hispanic whites; American Indians 
and Alaska Natives had the highest prevalence at 15.9% (CDC, 2014).  
 CVD and diabetes share a number of individual risk factors, including high blood 
pressure, dyslipidemia, and obesity (Smith, 2007).  Increased fasting glucose is essentially the 
definition of prediabetes (CDC, 2014).  Together, these risk factors – high blood pressure, 
dyslipidemia, increased fasting glucose, and obesity – compose the Metabolic Syndrome as it is 
currently defined by the International Diabetes Foundation (Alberti et al., 2009). 
 The concept of the Metabolic Syndrome was first proposed by Gerald Reaven in 1988 
(Reaven, 1988).  He termed it Syndrome X and implicated insulin resistance as the underlying 
cause.  It was subsequently called many other things, but is now most commonly referred to as 
the Metabolic Syndrome.  There has been much debate over the underlying cause of the 
Metabolic Syndrome.  Earlier studies implicated insulin resistance (Ferrannini, Haffner, 
Mitchell, & Stern, 1991; Reaven, 1988), but more recently focus has turned to visceral, 
abdominal obesity and has shown it to be an independent predictor of insulin resistance as well 
as the other features of the Metabolic Syndrome (Carr et al., 2004; Wagenknecht et al., 2003). 
 Determining the underlying cause of the Metabolic Syndrome is beyond the scope of this 
thesis.  It is generally agreed, however, that the Metabolic Syndrome is a clustering of 
interrelated metabolic risk factors that increase the risk of CVD and diabetes and that it increases 
the risk of diabetes more than it increases the risk of CVD (Ford et al., 2008; Gami et al., 2007).  
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Getting a clear picture of exactly how much the Metabolic Syndrome increases the risk for CVD 
and diabetes can be difficult as studies are often conducted among very different populations, 
using different diagnostic criteria, and with different outcomes of interest.  However, meta-
analyses have indicated that Metabolic Syndrome is associated with approximately 1.5 to 2 times 
the risk of incident CVD and CVD related death, even after controlling for traditional 
cardiovascular risk factors (Galassi, Reynolds, & He, 2006; Gami et al., 2007).  The degree to 
which the Metabolic Syndrome increases the risk for diabetes depends on how many components 
of the syndrome an individual has.  Risk increases with the number of components present and it 
has been shown that having 3 or 4 components of the Metabolic Syndrome may increase the risk 
for incident diabetes by over 10 or 20 times, depending on the combination of risk factors (Ford 
et al., 2008; Wilson, D’Agostino, Parise, Sullivan, & Meigs, 2005).  Meta-analyses and other 
studies indicate that the Metabolic Syndrome increases the risk of incident diabetes by 3 to 7 
times, and that this increase in risk is independent of other risk factors such as fasting insulin 
(Aschner, 2010; Ford et al., 2008; Hanley et al., 2005; Lorenzo et al., 2003).  It was estimated 
that between 2003 and 2006 approximately 34% of adults 20 years of age and over had the 
Metabolic Syndrome; non-Hispanic black males were about half as likely to have the Metabolic 
Syndrome as non-Hispanic white males and non-Hispanic black and Mexican American females 
were about 1.5 times as likely to have the Metabolic Syndrome as non-Hispanic white females 
(Ervin, 2009).   
  The components of the Metabolic Syndrome – abdominal obesity, high blood pressure, 
low HDL cholesterol, high triglycerides, and high fasting glucose – are all cardiometabolic risk 
factors on their own and it has been suggested that the predictive ability of the Metabolic 
Syndrome for CVD and diabetes represents little more than the sum of its parts (Cameron et al., 
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2007; Ford et al., 2008).  However, Cameron et al. (2007) conducted their study with a sample of 
about 3,000 Mauritians, a population with relatively low waist circumference, and found that the 
waist circumference cut points for 2 of the 3 definitions of Metabolic Syndrome that they used 
did not perform well in that population.  The third definition of Metabolic Syndrome used waist-
to-hip ratio instead of waist circumference to define abdominal obesity, and using this definition 
the researchers did indeed find that individuals with the Metabolic Syndrome were at a 2 fold 
increased risk for diabetes, even when controlling for all the individual components of the 
Metabolic Syndrome. 
 The Metabolic Syndrome is of interest primarily because it helps to identify individuals 
who are at increased risk of both type 2 diabetes and CVD, despite whether it is more predictive 
of CVD and diabetes than the sum of its parts or it is simply a collection of cardiometabolic risk 
factors that tend to present together and confer additive risks to an individual.  It is therefore 
important that individuals with this cluster of risk factors be identified for intervention and 
treatment.  Several organizations have proposed diagnostic criteria for identifying these 
individuals.   
  
2.2  Diagnostic Criteria for the Metabolic Syndrome 
 The first proposed diagnostic criteria came from the World Health Organization (WHO) 
and emphasized evidence of insulin resistance as a requirement for diagnosis of the Metabolic 
Syndrome (Alberti & Zimmet, 1998).  The WHO criteria required an individual have insulin 
resistance plus two additional risk factors – obesity, hypertension, high triglycerides or reduced 
HDL cholesterol.  In 2001, the National Cholesterol Education Program (NCEP) Adult 
Treatment Panel III (ATP III) released its own criteria for defining the Metabolic Syndrome 
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(NCEP ATP III, 2002).  The ATP criteria did not require insulin resistance or any other single 
risk factor as necessary for diagnosis of the Metabolic Syndrome.  Instead, NCEP suggested that 
the presence of 3 out of 5 risk factors – abdominal obesity, elevated triglycerides, low HDL 
cholesterol, elevated blood pressure, and elevated fasting glucose – be the basis for the diagnosis 
of Metabolic Syndrome.  These risk factors were chosen as the basis for diagnosis because they 
were the components of Metabolic Syndrome that can most readily be measured through routine 
clinical evaluation, unlike insulin resistance and a proinflammatory state.   
 In 2005, the International Diabetes Federation (IDF) and the American Heart 
Association/National Heart, Lung, and Blood Institute (AHA/NHLBA) met to try to reconcile 
the different diagnostic criteria for the Metabolic Syndrome (Alberti, Zimmet, Shaw, & IDF 
Epidemiology Task Force Consensus Group, 2005).  However, the recommendations that 
emerged from that meeting were still conflicting.  The IDF agreed with the ATP III 
recommendations that insulin resistance not be required for a diagnosis, but recommended 
instead that abdominal obesity be required as 1 of 5 risk factors with the remaining four risk 
factors largely unchanged from the ATP III definitions.  Under this definition, abdominal obesity 
plus 2 or more of the remaining 4 risk factors would constitute a diagnosis of Metabolic 
Syndrome.  The IDF also suggested that waist circumference may provide a simple and useful 
screening tool for Metabolic Syndrome.  The AHA/NHLBI recommendations were similar but 
did not require abdominal obesity for diagnosis.  These organizations recently met again and 
agreed that waist circumference should not be required for diagnosis (Alberti et al., 2009).  
Therefore, the presence of 3 or more of 5 risk factors – abdominal obesity, high blood pressure, 
low HDL cholesterol, high triglycerides, and high fasting glucose – constitute one of the most 
recent and widely used definitions of Metabolic Syndrome.  These recommendations also 
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include clinical cut points for determining whether each risk factor can be considered present in 
an individual.  These cut points are displayed in Table 1 and are the cut points used for the 
purposes of this thesis.  It has been pointed out that the 5 variables in this definition are not used 
as continuous variables but instead as risk factors that are either present or absent, which makes 
it a less than perfect tool for diagnosis; they cannot be used in the sort of risk calculator for CVD 
or diabetes that treats the variables continuously (Després et al., 2008).   
 
Table 1.  Criteria for Metabolic Syndrome Diagnosis 
Measure   Cut Points 
   Elevated waist circumference Population specific 
cut points 
   
High Blood Pressure  Systolic ≥ 130 and/or 
diastolic ≥ 85 mm Hg 
   
Low HDL Cholesterol  <40 mg/dL in males; 
<50 mg/dL in females 
   
High Triglycerides  ≥ 150 mg/dL 
   
High Fasting Glucose   ≥ 100 mg/dL 
Criteria from (Alberti et al., 2009) 
  
 
2.3  Anthropometric Measures for Risk Classification 
 It has long been known that obesity is associated with the risk factors that compose the 
Metabolic Syndrome, though it has been debated whether they are more closely associated with 
total absolute fat or abdominal obesity in particular (Kannel et al., 1991).  Total absolute fat is 
most often assessed by Body Mass Index (BMI), whereas abdominal fat is most often assessed 
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with Waist Circumference (WC).  Waist-to-height ratio (WHtR) has also been proposed as a 
measure of obesity that takes the bodily distribution of fat into account in a way that BMI does 
not.  All three of these measures have been proposed as simple screening tools to identify 
individuals that may be at increased risk for the Metabolic Syndrome, its component risk factors, 
CVD, diabetes, or mortality.  BMI has emerged as the measure most commonly used.  Much 
work has been done to determine which body measurement is the most useful predictor 
(Ashwell, Gunn, & Gibson, 2012; Christian, Mochari, & Mosca, 2009; Czernichow, Kengne, 
Stamatakis, Hamer, & Batty, 2011; Huxley, Mendis, Zheleznyakov, Reddy, & Chan, 2010; Lee, 
Huxley, Wildman, & Woodward, 2008; van Dijk, Takken, Prinsen, & Wittink, 2012; Vazquez, 
Duval, Jacobs, & Silventoinen, 2007), although it is difficult to get a clear picture of which 
measurements perform best due to the varying methods and study populations.  It has been 
demonstrated that the relationship between these anthropometric indices and cardiometabolic 
risk factors varies by race (Christian et al., 2009), which makes meta-analyses that include data 
from several different populations difficult to interpret.   
 A meta-analysis of over 82,000 British individuals from 9 cohorts found that greater WC 
was associated with increased risk of CVD mortality after controlling for traditional 
cardiometabolic risk factors and that BMI was not (Czernichow et al., 2011).  Another meta-
analysis that focused solely on the outcome of incident diabetes (Vazquez et al., 2007) analyzed 
data from 32 studies from around the world and found that the relative risks for incident diabetes 
were essentially the same for BMI and WC.  However, other research has indicated that 
abdominal obesity is more important to the development of diabetes and suggests that WC is a 
stronger predictor of diabetes than BMI (Klein et al., 2007).   
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 Yet another meta-analysis of 20 articles with data on over 45,000 European and US 
Caucasian men and women found that WC correlated more highly with blood pressure, 
triglycerides, and fasting blood glucose than did BMI or WHtR; for HDL cholesterol, the 
correlation with WC was about the same as BMI and both were more highly correlated than 
WHtR (Van Dijk et al., 2012).  The authors therefore suggested that WC be used in clinical 
practice and research studies above BMI. 
 Perhaps most relevant to this thesis due to the similar research questions, outcomes, and 
methods of the studies included, Ashwell et al. (2012) conducted a meta-analysis of 31 primary 
studies from all over the world that used ROC curve analysis to compare the utility of WHtR 
against either BMI or WC in classifying individuals with diabetes, hypertension, and 
dyslipidemia, among other outcomes.  They found that for all outcomes WHtR improved 
classification over BMI by 4-5% and that WC improved classification over BMI by 3%.  This 
meta-analysis evaluated many of the same studies as an earlier meta-analysis by Lee et al. (2008) 
that reached similar conclusions.  The authors therefore recommended that WHtR be considered 
as a screening tool before BMI and WC, as has been suggested before (Ashwell & Hsieh, 2005).   
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Chapter III 
METHODS 
 
3.1  Study Purpose 
 The purpose of this thesis is to determine which anthropometric measure – BMI, WC, or 
WHtR – is the best discriminator for detecting individuals with the Metabolic Syndrome and its 
components – high blood pressure, low HDL cholesterol, high triglycerides, and high fasting 
glucose – in a large, nationally representative, and multi-ethnic sample of adults in the United 
States.   
 
3.2  Data Source 
 Data were obtained from the 2007-2008 and 2009-2010 cycles of the National Health and 
Nutrition Examination Survey (NHANES), a program of the National Center for Health 
Statistics.  NHANES utilizes a large, multi-stage probability sample design to facilitate 
nationally representative estimates and collects data through a questionnaire, a physical 
examination, and laboratory testing.  It is therefore used to set US national standards for 
measurements such as weight and blood pressure.  This thesis uses data from the questionnaire, 
examination, and laboratory components of NHANES.  Health interviews are conducted in 
respondents’ homes while the examination and laboratory components are conducted is a mobile 
examination center (MEC).  All data is collected by trained personnel.      
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3.3  Study Sample 
 From 2007-2010, NHANES collected data on 20,686 individuals.  Only adults aged 20-
65 with complete information on height, weight, waist circumference, blood pressure, HDL 
cholesterol, fasting glucose, and triglycerides were included in the sample for this thesis.   
 
3.4  Variables 
 This thesis considered several anthropometric measures, all of which are continuous.  The 
outcomes were also continuous, but were dichotomized for the purposes of this thesis.  For 
example, each individual has a specific systolic blood pressure, but they have been dichotomized 
for this thesis as either having high blood pressure or not having high blood pressure.  The cut 
points for the outcomes are clinical diagnosis criteria for the Metabolic Syndrome as proposed by 
the International Diabetes Federation Task Force on Epidemiology and Prevention, the National 
Heart, Lung, and Blood Institute, and the American Heart Association, among others (Alberti, 
2009).   
 
3.4.1  Body Mass Index (BMI) 
 Height and weight were recorded for each individual during the mobile examination 
portion of the survey.  Standing height was recorded in centimeters as each participant stood with 
their heels together against a straight backboard.  Participants were weighed in kilograms with a 
digital scale while wearing only a standard gown and underpants.  BMI was computed by 
dividing a participant’s weight in kilograms by their height in meters squared. 
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3.4.2  Waist Circumference (WC) 
 Waist circumference was measured in centimeters for each participant.  Measurements 
were taken just above the uppermost lateral border of the right ilium. 
 
3.4.3  Waist to Height Ratio (WHtR) 
 Waist to height ratio was computed as waist circumference in centimeters divided by 
standing height in centimeters.  
 
3.4.4  High Blood Pressure 
 Systolic and diastolic blood pressure was recorded for participants 8 years and older 
during the MEC portion of the survey.  Both were measured after the participant sat and rested 
quietly for 5 minutes.  Three measurements were taken for both systolic and diastolic blood 
pressure, and if one measurement was incomplete then a fourth measurement was taken.  For this 
thesis, an individual’s systolic and diastolic blood pressure was computed as the mean of all non-
missing measurements.   
 Individuals were classified as having high blood pressure if they met one of three criteria: 
systolic blood pressure greater than or equal to 130, diastolic blood pressure greater than or equal 
to 85, or if they’ve been told by a doctor that they have hypertension and are currently taking 
medication to control their blood pressure.  Individuals that did not meet one of these three 
criteria were classified as not having high blood pressure. 
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3.4.5  Low HDL Cholesterol (HDL) 
 HDL cholesterol was measured in mg/dL for all NHANES participants 6 years and older.  
Blood was drawn and HDL levels were determined by Roche Modular P chemistry analyzer.  
 Males with HDL cholesterol less than 40 mg/dL and females with HDL cholesterol less 
than 50 mg/dL were classified as having low HDL.    
 
3.4.6  High Fasting Glucose 
 Fasting glucose was recorded in mg/dL for a subsample of NHANES participants 12 
years and older that were examined during the morning MEC session.  Eligible participants also 
had to have fasted for at least 9 hours prior to examination.  Blood was drawn and fasting 
glucose levels were determined by Roche Modular P chemistry analyzer.  Individuals that had 
hemophilia, that were taking medication for diabetes, and that had not fasted for at least 9 hours 
prior to the examination were excluded. 
 Individuals were classified as having high fasting glucose if they had fasting glucose 
greater than or equal to 100 mg/dL or if they had been told by a doctor that they have diabetes or 
prediabetes and reported currently taking medication to lower blood sugar. 
 
3.4.7  High Triglycerides 
 Triglycerides were measured in mg/dL for a subsample of participants 12 years and older 
that were examined during the morning MEC session.  Blood was drawn and triglyceride levels 
were determined by Roche Modular P chemistry analyzer. 
 Individuals were classified as having high triglycerides if they had triglycerides greater 
than or equal to 150 mg/dL. 
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3.4.8  Metabolic Syndrome 
 Under the definition used for this thesis (Alberti et al., 2009), the Metabolic Syndrome is 
diagnosed on the basis of having 3 of the following 5 risk factors: abdominal obesity, high blood 
pressure, low HDL, high fasting glucose, and high triglycerides.  Since measures of obesity are 
being used to classify individuals, the Metabolic Syndrome is defined here as having at least 2 of 
the remaining 4 risk factors, similar to the old IDF definition before the requirement for 
abdominal obesity was dropped (Alberti et al., 2005).   
 
3.5  Statistical Analysis 
 In order to compare the utility of different anthropometric measures for classifying 
individuals, each measure was considered as a screening test for the presence of the Metabolic 
Syndrome and its component risk factors.  For each of these tests empirical ROC curves were 
constructed and AUC statistics were compared.  Therefore, an ROC curve was constructed for 
each body measurement-outcome combination.  Sampling weights provided by NHANES were 
used in the construction of the ROC curves.  Individuals that were tested for fasting glucose and 
triglycerides and that were required to fast before the MEC session were a smaller subsample of 
the larger MEC sample, so unique sampling weights are provided for analyses restricted to that 
subsample of individuals.  The fasting subsample weights were used for all analyses in this 
thesis.   
 Many standard statistical packages that construct ROC curves do not take into account 
sampling weights.  For this thesis, weighted contingency tables were constructed for each 
relevant cut point of the body measurement.  The weighted counts in these tables allowed for the 
calculation of sensitivity and specificity at each cut point.  The sensitivity was then plotted 
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against 1-specificity to create the ROC curves.  AUC statistics were calculated by approximating 
the definite integral of the ROC curves with the trapezoidal rule.  
 Standard methods for estimating the variance of AUC statistics do not take into account 
survey design or sampling weights.  Variances for the AUC statistics and differences in AUC 
statistics were estimated with jackknife repeated replication (Wolter, 2007).  In a stratified 
cluster design, jackknife repeated replication works by dropping out one primary sampling unit 
(PSU) at a time and reweighting the remaining PSUs in that stratum.  In a stratum with 2 PSUs, 
the weights for one PSU will be set to zero and the weights for the other PSU will be multiplied 
by 2.  In a stratum with 3 PSUs, the weights for one PSU will be set to zero and the weights for 
the others will be multiplied by 1.5.  This process is repeated for each PSU, resulting in as many 
replicates as there are PSUs in the sample.  The sample for this thesis contained 63 PSUs.  Thus, 
63 replicates were constructed, each with its own set of weights.  A separate estimate is then 
produced for each replicate, resulting in 63 estimates.  The variation in these estimates is the 
basis for estimating the standard error of the statistic: the sum of the squared differences between 
the full sample estimate of the statistic and each replicate estimate is divided by a factor that 
depends on the number of PSUs in that stratum.   
 AUC statistics and 95% confidence intervals were calculated for each combination of 
body measurement and risk factor.  Within each risk factor, the AUC statistics for each body 
measurement were compared to the AUC statistic for BMI, which was the reference, by 
subtracting the AUC for BMI from the AUC for each other measurement.  Thus, a negative 
difference indicates that BMI had a larger AUC statistic and a positive difference indicates that 
BMI had a smaller AUC statistic.  The statistical significance of these differences was calculated 
with a standard t-test; the estimated difference in AUC statistics was divided by the standard 
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error of that difference, as estimated with jackknife repeated replication.  The resulting statistic 
has a Student’s t distribution with degrees of freedom equal to the number of clusters in the 
sample minus the number of strata, in this case 63-31=32 (Heeringa, West, and Berglund, 2010).  
 One overall analysis was conducted that included males and females of all races and 
separate analyses were conducted for the three races with the largest sample size in NHANES, 
non-Hispanic whites, non-Hispanic blacks, and Mexican Americans.  All analyses were 
conducted in the R statistical computing environment version 3.0.3 (R Core Team, 2014) with 
the survey package (Lumley, 2012).  
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Chapter IV 
RESULTS 
 
4.1  Descriptive Statistics 
 Demographic characteristics, frequencies for the outcomes, and summary statistics for the 
anthropometric measures are displayed in Table 2.  All reported frequencies are unweighted.  
There were 3,769 total observations in the study sample.  This was reduced from 20,686 in the 
total NHANES 2007-2010 sample.  Many observations were removed from analysis because of 
the 20-65 age restriction, but many more were removed because the fasting sub-sample with data 
on fasting glucose and triglycerides was a small subset of the overall sample.   
 Forty-two percent (42%) of the sample was between the ages of 20 and 39, 45% was 
between 40 and 59, and 13% was between 60 and 65.  The sample was almost evenly split 
between male (51%) and female (48%).  Non-hispanic whites were the largest group (43%) and 
the rest of the sample was approximately equal parts non-Hispanic black (19%), Mexican 
American (21%), and other or multi-racial (17%).   
 High blood-pressure (33%), low HDL cholesterol (31%), and high triglycerides (29%) 
were each present in about a third of the sample.  High fasting glucose (48%) and the Metabolic 
Syndrome (43%) were present in almost half of the sample.  BMI ranged from about 15 kg/m2 to 
about 85 kg/m2 with a mean of 29 kg/m2; WC ranged from about 59 cm to 167 cm with a mean 
of 98 cm; and WHtR ranged from 0.37 to 1.03 with a mean of 0.58.
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Table 2.  Characteristics of Study Sample (n=3,769)
Variable N % Minimum Mean Maximum SD
Age
    20-39 1,594     42          
    40-59 1,697     45          
    60-65 478        13          
Sex
    Male 1,833     51          
    Female 1,936     48          
Race
    Non-Hispanic White 1,612     43          
    Non-Hispanic Black 720        19          
    Mexican American 791        21          
    Other/Multi-Racial 646        17          
High Blood Pressure
    Yes 1,232     33          
    No 2,537     67          
Low HDL
    Yes 1,170     31          
    No 2,599     69          
High Fasting Glucose
    Yes 1,826     48          
    No 1,943     52          
High Triglycerides
    Yes 1,079     29          
    No 2,690     71          
Metabolic Syndrome
   Yes 1,616     43          
   No 2,153     57          
BMI 15.02 29.00 84.87 6.69
WC 59.10 98.14 167.00 15.99
WHtR 0.37 0.58 1.03 0.10
*Frequencies are unweighted and are not representative of US population
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4.2  ROC Curves 
 All weighted, empirical ROC curves are presented in the Appendix.  For the overall 
sample and within each race subgroup, the diagnostic utility of WC, WHtR, and BMI are 
compared for the Metabolic Syndrome and each component outcome.  On the curve for BMI, the 
cut points corresponding to a BMI of 25 and a BMI of 30 are indicated as a reference since these 
are traditional BMI cut points for classifying overweight and obesity, respectively, and increased 
cardiometabolic risk.   
 
4.3  AUC Statistics 
4.3.1  Overall  
 AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic 
performance of WC and WHtR to BMI are reported in Table 3 for the entire sample (n=3,769).  
WC performed better than BMI at classifying individuals with and without the Metabolic 
Syndrome (p<0.001) and all of the component risk factors except for HDL cholesterol.  WHtR 
performed better than BMI at classifying Metabolic Syndrome (p=0.048), high blood pressure 
(p=0.006), and high triglycerides (p=0.007).  Neither WC nor WHtR performed better than BMI 
at classifying low HDL cholesterol.  WHtR performed no better than BMI at classifying high 
fasting glucose. 
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Table 3.  AUC statistics and 95% Confidence Intervals, Overall (n=3,769)
AUC Lower 95% CI Upper 95% CI p
Blood Pressure
BMI 0.682 0.650 0.714
WC 0.703 0.675 0.731 0.001
WHtR 0.694 0.667 0.722 0.006
HDL Cholesterol
BMI 0.671 0.639 0.702
WC 0.663 0.635 0.691 0.105
WHtR 0.674 0.641 0.708 0.461
Fasting Glucose
BMI 0.664 0.634 0.695
WC 0.698 0.667 0.728 <0.001
WHtR 0.674 0.645 0.703 0.123
Triglycerides
BMI 0.656 0.632 0.679
WC 0.677 0.654 0.699 0.001
WHtR 0.676 0.652 0.700 0.007
Metabolic Syndrome
BMI 0.728 0.699 0.757
WC 0.752 0.724 0.780 <0.001
WHtR 0.740 0.711 0.769 0.048
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4.3.2  Non-Hispanic Whites 
 AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic 
performance of WC and WHtR to BMI are reported in Table 4 for non-Hispanic whites 
(n=1,612).  Among non-Hispanic whites, WC performed better than BMI at classifying the 
Metabolic Syndrome (p=0.038) and at classifying high fasting glucose (p<0.001).  WC did 
slightly better than BMI at classifying high blood pressure and high triglycerides and slightly 
worse than BMI at classifying low HDL cholesterol, but none of these differences were quite 
statistically significant at the 95% confidence level.  WHtR was not significantly different from 
BMI at classifying Metabolic Syndrome or any of the component risk factors. 
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Table 4. AUC statistics and 95% Confidence Intervals, non-Hispanic whites (n=1,612)
AUC Lower 95% CI Upper 95% CI p
Blood Pressure
BMI 0.702 0.660 0.744
WC 0.716 0.678 0.754 0.079
WHtR 0.712 0.676 0.748 0.117
HDL Cholesterol
BMI 0.680 0.637 0.724
WC 0.669 0.628 0.709 0.068
WHtR 0.676 0.631 0.721 0.523
Fasting Glucose
BMI 0.675 0.632 0.718
WC 0.707 0.665 0.749 <0.001
WHtR 0.680 0.639 0.721 0.472
Triglycerides
BMI 0.670 0.634 0.706
WC 0.683 0.647 0.719 0.081
WHtR 0.685 0.649 0.721 0.148
Metabolic Syndrome
BMI 0.742 0.701 0.783
WC 0.757 0.717 0.797 0.038
WHtR 0.744 0.703 0.784 0.830
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4.3.3  Non-Hispanic Blacks 
 AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic 
performance of WC and WHtR to BMI are reported in Table 5 for non-Hispanic blacks (n=720).  
Among non-Hispanic blacks, WC performed better than BMI at classifying the Metabolic 
Syndrome (p<0.001) and every component risk factor, except for low HDL cholesterol where a 
slightly better performance was not statistically significant (p=0.090).  WHtR was significantly 
better than BMI at classifying Metabolic Syndrome (p<0.001), and every component risk factor 
except for high triglycerides. 
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Table 5.  AUC statistics and 95% Confidence Intervals, non-Hispanic blacks (n=720)
AUC Lower 95% CI Upper 95% CI p
Blood Pressure
BMI 0.628 0.572 0.685
WC 0.666 0.608 0.724 <0.001
WHtR 0.659 0.603 0.715 0.002
HDL Cholesterol
BMI 0.662 0.598 0.726
WC 0.679 0.626 0.733 0.090
WHtR 0.688 0.634 0.741 0.043
Fasting Glucose
BMI 0.634 0.590 0.677
WC 0.676 0.630 0.722 <0.001
WHtR 0.656 0.608 0.703 0.009
Triglycerides
BMI 0.606 0.554 0.659
WC 0.640 0.589 0.690 0.036
WHtR 0.618 0.566 0.670 0.394
Metabolic Syndrome
BMI 0.705 0.671 0.738
WC 0.748 0.715 0.781 <0.001
WHtR 0.739 0.705 0.773 <0.001
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4.3.4  Mexican Americans 
 AUC statistics, 95% confidence intervals, and p values for comparing the diagnostic 
performance of WC and WHtR to BMI are reported in Table 6 for Mexican Americans (n=791).  
Among Mexican Americans, WC performed better than BMI at classifying the Metabolic 
Syndrome (p=0.001), high blood pressure (p<0.001), and high triglycerides (p=0.001).  WC 
performed significantly worse than BMI at classifying low HDL cholesterol (p=0.017) and 
slightly better than BMI at classifying high fasting glucose, though this was not statistically 
significant (p=0.061).  WHtR was not statistically significantly different from BMI for Metabolic 
Syndrome or any of the risk factors.  The performance of WHtR was slightly better than BMI for 
the Metabolic Syndrome (p=0.094), high blood pressure (p=0.055), and high triglycerides 
(p=0.065), but none of these were quite statistically significant at the 95% confidence level.  
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Table 6.  AUC statistics and 95% Confidence Intervals, Mexican Americans (n=791)
AUC Lower 95% CI Upper 95% CI p
Blood Pressure
BMI 0.666 0.624 0.708
WC 0.713 0.672 0.753 <0.001
WHtR 0.694 0.658 0.730 0.055
HDL Cholesterol
BMI 0.687 0.648 0.726
WC 0.665 0.621 0.708 0.017
WHtR 0.679 0.641 0.717 0.375
Fasting Glucose
BMI 0.647 0.608 0.687
WC 0.666 0.625 0.706 0.061
WHtR 0.652 0.612 0.692 0.663
Triglycerides
BMI 0.639 0.596 0.681
WC 0.669 0.636 0.702 0.001
WHtR 0.659 0.617 0.701 0.065
Metabolic Syndrome
BMI 0.715 0.681 0.748
WC 0.741 0.707 0.775 0.001
WHtR 0.732 0.700 0.764 0.094
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Chapter V 
DISCUSSION AND CONCLUSION 
 
 In the complete sample, which is representative of the US adult population aged 20-65, 
WC did a better job than BMI at classifying individuals with and without the Metabolic 
Syndrome and all of the component risk factors except for HDL cholesterol.  For HDL 
cholesterol, there was no significant difference between WC and BMI.  WC did a better job than 
BMI at classifying individuals with and without the Metabolic Syndrome across all of the race 
subgroups as well.  The utility of WC in classifying the component risk factors varied a bit 
between races.  For the most part, WC performed better at classifying the component risk factors 
among non-Hispanic blacks and Mexican Americans.  However, among whites it only performed 
better than BMI at classifying high fasting glucose.  In summary, for every analysis in the overall 
sample and in the race subgroups, WC performed significantly better than BMI or no different 
from BMI, except for low HDL cholesterol among Mexican Americans where it performed 
significantly worse than BMI.   
 WHtR performed significantly better than BMI at classifying individuals with and 
without the Metabolic Syndrome in the entire sample and among non-Hispanic blacks.  Among 
non-Hispanic whites and Mexican Americans, WHtR was not significantly different from BMI at 
classifying the Metabolic Syndrome.  Results were mixed for the component risk factors.  In the 
full sample, WHtR performed better than BMI at classifying high blood pressure and high 
triglycerides.  Among non-Hispanic blacks, WHtR performed better than BMI at classifying high 
blood pressure, low HDL cholesterol, and high fasting glucose.  However, WHtR was not 
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significantly different from BMI at classifying any of the risk factors among non-Hispanic 
whites and Mexican Americans. 
 The results of this thesis differ slightly from the results of the meta-analysis by Ashwell 
et al. (2012) who found that WHtR performed better than WC and BMI at classifying various 
outcomes, including the Metabolic Syndrome, dyslipidemia, and hypertension.  This meta-
analysis reviewed 31 articles that used methods similar to the methods for this thesis and that 
reported AUC statistics.  However, out of the 31 studies included in the meta-analysis, only 2 
were conducted in the US population and one of those only included women.  The authors also 
point out that before their meta-analysis it was difficult to prove the utility of WHtR over WC in 
populations without a lot of variability in height and that 15 of the studies included the meta-
analysis were conducted among Asian populations that tend to have shorter average heights.   
 Of the 2 studies conducted in the US and included in Ashwell et al.’s meta-analysis 
(2012), one found that among US women WHtR and WC performed nearly identically at 
classifying CVD and that both were superior to BMI (Page et al., 2009).  This thesis reached 
fairly similar conclusions, though the outcomes in this thesis were cardiometabolic risk factors 
and not CVD itself and the sample in this thesis consisted of both men and women.  The other 
study, using an older sample of US adults from NHANES, did not compare WHtR and WC 
directly but found that WHtR and WC performed similarly at classifying diabetes and that both 
performed better than BMI (Li, Ford, Zhao, Kahn, & Mokdad, 2010).  In contrast, this thesis 
found that WC performed significantly better than BMI at classifying high fasting glucose while 
WHtR did not.  However, this thesis used a lower cut point to define high fasting glucose and 
classified individuals who had been told by a doctor that they had diabetes and were taking 
medication to lower their blood sugar as having high fasting glucose as well. 
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 The results of this thesis also differ with the meta-analysis of Lee et al. (2008) which 
concluded that WHtR was the best anthropometric measure for classifying hypertension, 
diabetes, and dyslipidemia.  However, the 10 studies in the Lee et al. (2008) meta-analysis were 
all included in the Ashwell et al. (2012) meta-analysis and none of them were conducted in the 
US population.   
 The results of this thesis largely concur with the conclusions reached by Van Dijk et al. 
(2012) in their meta-analysis.  They reviewed articles that used different methods than this thesis 
and examined the correlation coefficients between anthropometric measurements and risk factors 
including high blood pressure, low HDL cholesterol, high triglycerides, and high fasting glucose.  
Twenty studies were reviewed, including 4 of which were conducted in US populations.  They 
found that WC was more highly correlated with these risk factors than either WHtR or BMI.    
 The results of this thesis suggest that in a large, multi-ethnic, and nationally 
representative sample of US adults aged 20-65, WC is superior to BMI at classifying the 
Metabolic Syndrome as well as many of its component risk factors.  This thesis did not explicitly 
test the statistical significance of differences between WC and WHtR.  However, WC performed 
better than BMI more often than WHtR performed better than BMI across the outcomes and race 
subgroups.  In many cases, WC performed significantly better than BMI where WHtR did not.  
In some cases, both WC and WHtR performed better than BMI but WC performed slightly 
better.  These results are also largely in agreement with similar studies conducted in the US 
population.  The few discrepancies between this thesis and previous research are likely due to 
different study populations, different methods, and/or different outcome definitions.  These 
results also fit in with the current thinking that abdominal obesity is a stronger risk factor for the 
Metabolic Syndrome than is body mass. 
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 When looking at the results for classifying the Metabolic Syndrome in the overall sample, 
the differences between the AUC for BMI (0.728) and the AUCs for WC (0.752) and WHtR 
(0.74) do not appear to be especially large, but it must be remembered that the ultimate utility of 
using an anthropometric measure for classification depends on the cut point chosen for that 
anthropometric measure.  It is useful to examine the ROC curves and to consider a hypothetical 
scenario to illustrate the magnitude of these differences.  Using this sample, the weighted 
estimate of the number of adults aged 20-65 with Metabolic Syndrome in the US between 2007 
and 2010 is 67,296,904.  Suppose a BMI of 25 (overweight) was used as a cut point to screen 
this entire population so that individuals with a BMI of 25 or greater were then assessed for the 
Metabolic Syndrome.  This BMI cut point would result in a specificity of 0.442 and a sensitivity 
of 0.863 and would identify 58,066,617 true positives.  If WC was instead used for the screening 
with a cut point of 89 cm, this would result in an almost identical specificity of 0.448 and a 
sensitivity of 0.882 which would identify 59,373,231 true positives.  Since the specificities are 
nearly identical, the two measures would identify approximately the same amount of true 
negatives, but WC would identify over 1.3 million more true positives than BMI.   
  Again, the selection of appropriate cut points will largely determine how exactly these 
measures perform in practice, but the results of this thesis demonstrate that across the range of all 
possible cut points, WC performs better than BMI.  Currently, it is recommended that different 
WC cut points be used in different populations and it is not entirely clear which cut points may 
be optimal (Alberti et al., 2009).  Further research should attempt to determine optimum WC cut 
points for risk classification in the US population.  The performance of these anthropometric 
measures and the cut points that are chosen likely vary by sex as well.  One limitation of this 
thesis is that analyses were not conducted by sex in an effort to preserve large sample sizes.  The 
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clinical performance of WC would also of course depend on how WC is measured exactly and 
whether or not patients will allow it.  How to find and measure the waist is not always totally 
clear.  Measuring a patient’s WC is also slightly more invasive than measuring a patient’s BMI 
in that it requires close physical contact from the physician.  This may make certain patients less 
willing to consent to measurement.     
 Of course, screening the entire adult US population to identify those at risk for the 
Metabolic Syndrome would be difficult, so primary prevention for the Metabolic Syndrome, 
CVD, and diabetes remains crucial.  Public health must ensure that prevention efforts for these 
diseases continue, especially in vulnerable populations.  In the case of cardiovascular disease, the 
American Heart Association has noted that primary and secondary prevention efforts are often 
lacking in disadvantaged communities and has recommended the dissemination and 
implementation of effective prevention strategies in these communities (Heidenreich et al., 
2011).  Improving diagnostic screening tools to identify those with the Metabolic Syndrome and 
at risk for CVD and diabetes can and should be a part of these primary and secondary prevention 
strategies but will not alone be sufficient to control increasing prevalence of CVD and diabetes.   
 This thesis has shown that WC is a better screening tool than BMI for identifying 
individuals at increased risk of the Metabolic Syndrome.  WHtR also performs better than BMI 
in many cases, though its performance is less consistent, especially across ethnicities.  WHtR 
also does not perform as well as WC at classifying high fasting glucose which is critical for 
diabetes prevention efforts.  WC should therefore be considered, over WHtR and especially over 
BMI, for risk stratification in clinical settings and research in the US adult population.
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